Ambeed.cn

首页 / 抑制剂/激动剂 / 泛素 / / b-AP15

b-AP15 {[allProObj[0].p_purity_real_show]}

货号:A619221 同义名: NSC 687852

b-AP15 is an inhibitor of the ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCHL5) and ubiquitin-specific-processing protease 14 (USP14). In purified 19S proteasomes, b-AP15 can inhibit DUB activity with an IC50 of 2.1 μM.

b-AP15 化学结构 CAS号:1009817-63-3
b-AP15 化学结构
CAS号:1009817-63-3
b-AP15 3D分子结构
CAS号:1009817-63-3
b-AP15 化学结构 CAS号:1009817-63-3
b-AP15 3D分子结构 CAS号:1009817-63-3
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

b-AP15 纯度/质量文件 产品仅供科研

货号:A619221 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]
JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]
BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]
J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]
PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]
更多 >
产品名称 DUB UCH USP/UBP 其他靶点 纯度
PR-619 +

Plpro, EC50: 14.2 μM

+++

UCH-L5, EC50: 12.8 μM

UCH-L3, EC50: 2.95 μM

+++

USP5, EC50: 4.90 μM

USP28, EC50: 6.24 μM

99%+
Degrasyn Bcr-Abl 98+%
VLX1570 +

DUB, IC50: ~10 μM

99%+
ML-323 ++++

USP1-UAF1, IC50: 76 nM

99%+
LDN-57444 ++++

UCH-L1, IC50: 0.4 μM

UCH-L3, IC50: 25 μM

99%+
TCID ++++

UCH-L3, IC50: 0.6 μM

98%
b-AP15 +++

UCHL5, IC50: 2.1 μM

98%
P 22077 ++

USP7, IC50: 8.6 μM

USP47, EC50: 8.74 μM

99%+
P005091 ++

USP47, IC50: 4.3 μM

USP7, EC50: 4.2 μM

99+%
IU1 ++

USP14, IC50: 4.7 μM

98%
NSC632839 +

USP2, EC50: 45 μM

USP7, EC50: 37 μM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。
产品名称 20S proteasome Proteasome 其他靶点 纯度
Ixazomib ++++

20S proteasome, IC50: 3.4 nM

20S proteasome, Ki: 0.93 nM

99%+
Delanzomib +++

Chymotrypsin-like proteasome, IC50: 3.8 nM

98%
Celastrol +

20S proteasome, IC50: 2.5 μM

98%
MLN9708 +++

20S proteasome, IC50: 3.4 nM

20S proteasome, Ki: 0.93 nM

99%
Bortezomib ++++

20S proteasome, Ki: 0.6 nM

98%
Oprozomib ++

20S proteasome LMP7, IC50: 82 nM

20S proteasome β5, IC50: 36 nM

99%+
Epoxomicin 99%
PI-1840 ++

Chymotrypsin-like proteasome, IC50: 27 nM

98%
VR23 +++

Trypsin-like proteasomes, IC50: 1 nM

Chymotrypsin-like proteasomes, IC50: 3 μM

98%
Carfilzomib ++

Proteasome, IC50: 5 nM

98%
(R)-MG-132 +

Proteasome, IC50: 100 nM

98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

b-AP15 生物活性

靶点
  • UCH

    UCHL5, IC50:2.1 μM

描述 The ubiquitin-specific peptidases (USPs) are the main members of the deubiquitinase(DUB) family. b-AP15 is an inhibitor of 19S proteasome deubiquitinase (DUB) with IC50 value of 6.5 μM[3]. In vitro, b-AP15 induced time- and dose-dependent apoptosis of the human multiple myeloma cell lines RPM18226 and U266. b-AP15 triggered processing of pro-caspase-3 and cleavage of ploy (ADP-ribose) polymerase in the human multiple myeloma cell. b-AP15 also induced caspase-independent apoptosis in primary human natural killer cells[4]. In vivo, administration of b-AP15 at 4 mg/kg once daily for 14 days was well tolerated, inhibited tumor growth, and prolong survival in human multiple myeloma xenograft models[5]. Treatment with b-AP15 at dose of 5 mg/kg inhibited tumor growth in SCID mice with FaDu human tumor xenograft and C57BL/6J mice with Lewis lung carcinomas (LLCs). Treatment with b-AP15 at dose of 2.5 mg/kg also inhibited tumor growth in BALB/c mice with orthotopic breast carcinoma. In addition, b-AP15 can inhibited organ infiltration in an acute myeloid leukemia model[6].
作用机制 b-AP15 blocks the DUB activity of the 19S regulatory particle (19S RP) without inhibiting the proteolytic activities of the 20S core particle (20S CP), and inhibits two proteasome-associated DUBs, USP14 and UCHL5, resulting in a rapid accumulation of high molecular weight ubiquitin conjugates and a functional proteasome shutdown[7].

b-AP15 细胞研究

细胞系 浓度 检测类型 检测时间 活动说明 数据源
CEM cells Cytotoxicity assay Cytotoxicity against human CEM cells, IC50=0.26 μM 19819135
HL60 cells Cytotoxicity assay Cytotoxicity against human HL60 cells in presence of RPMI1640 containing 10% fetal bovine serum by trypan blue exclusion test, CC50=0.13 μM 17499885
HSC4 cells Cytotoxicity assay Cytotoxicity against human HSC4 cells by MTT method, CC50=0.56 μM 17499885
human HSC2 Cytotoxicity assay Cytotoxicity against human HSC2 by MTT method, CC50=0.094 μM 17499885

b-AP15 动物研究

Dose Mice: 2.5 mg/kg, 5 mg/kg[3] (i.p.)
Administration i.p.

b-AP15 参考文献

[1]Lopez-Castejon G, Luheshi NM, et al. Deubiquitinases regulate the activity of caspase-1 and interleukin-1β secretion via assembly of the inflammasome. J Biol Chem. 2013 Jan 25;288(4):2721-33.

[2]D'Arcy P, Brnjic S, et al. Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nat Med. 2011 Nov 6;17(12):1636-40.

[3]Wang X, D'Arcy P, Caulfield TR, Paulus A, Chitta K, Mohanty C, Gullbo J, Chanan-Khan A, Linder S. Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15. Chem Biol Drug Des. 2015 Nov;86(5):1036-48.

[4]Feng X, Holmlund T, Zheng C, Fadeel B. Proapoptotic effects of the novel proteasome inhibitor b-AP15 on multiple myeloma cells and natural killer cells. Exp Hematol. 2014 Mar;42(3):172-82.

[5]Tian Z, D'Arcy P, Wang X, Ray A, Tai YT, Hu Y, Carrasco RD, Richardson P, Linder S, Chauhan D, Anderson KC. A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance. Blood. 2014 Jan 30;123(5):706-16.

[6]D'Arcy P, Brnjic S, Olofsson MH, Fryknäs M, Lindsten K, De Cesare M, Perego P, Sadeghi B, Hassan M, Larsson R, Linder S. Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nat Med. 2011 Nov 6;17(12):1636-40.

[7]D'Arcy P, Linder S. Proteasome deubiquitinases as novel targets for cancer therapy. Int J Biochem Cell Biol. 2012 Nov;44(11):1729-38.

b-AP15 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.38mL

0.48mL

0.24mL

11.92mL

2.38mL

1.19mL

23.84mL

4.77mL

2.38mL

b-AP15 技术信息

CAS号1009817-63-3
分子式C22H17N3O6
分子量 419.387
别名 NSC 687852
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Sealed in dry,2-8°C

溶解度

DMSO: 18 mg/mL(42.92 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方

4% DMSO+corn oil 1 mg/mL

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。